Abbott

Another first for a world's-first system that keeps the heartbeat in sync.

The first commercial implant of AVEIR DR is complete — a big step in pushing the boundaries of what's possible in cardiac care.

ISI: https://abbo.tt/3QQ4A4J

We’re helping people understand their glucose with real-time data so they can connect the dots about what habits work for them.

Meet Lingo: Our award-winning biowearable, honored by Fast Company and CES.

https://abbo.tt/3UZzc5p
https://abbo.tt/3CDUS0t

The Lingo Glucose System is for users 18 years and older not on insulin. It is NOT intended for diagnosis of diseases, including diabetes.

Our Q1 results are in, and the year is off to a strong start. We beat Street estimates and are raising our full-year guidance.

We’re leading in fast-growing markets and creating new ones with Q1 innovations like our high-protein nutrition shake, heart valve repair system and rapid blood test for concussion assessment. More here: https://abbo.tt/3xGDR3r